Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of local treatment for onychomycosis
NL-OMON52904Phase 4Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of miconazole and amorolfine in onychomycosis (3 arms), sponsored by Leiden University Medical Center. Primary endpoint: Cure of the index nail at 26 weeks. Started Feb 2020; status: active, not recruiting.
02
Drugs
miconazoleamorolfine
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NL-OMON52904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52904.